PTC THERAPEUTICS, INC. (PTCT) › Capital ExpendituresPTC THERAPEUTICS, INC. (PTCT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $165.1K2012: $189.0K2013: $846.0K2014: $4.66M2015: $2.72M2016: $1.78M2017: $3.10M2018: $7.10M2019: $13.76M2020: $17.84M2021: $28.21M2022: $32.02M2023: $28.44M2024: $6.50M2025: $8.86M$8.86M2011Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$8.86M+36.3%2024$6.50M-77.1%2023$28.44M-11.2%2022$32.02M+13.5%2021$28.21M+58.1%2020$17.84M+29.7%2019$13.76M+93.8%2018$7.10M+128.9%2017$3.10M+74.6%2016$1.78M-34.7%2015$2.72M-41.7%2014$4.66M+451.3%2013$846.0K+347.6%2012$189.0K+14.5%2011$165.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share